<< FDA strengthens safety information for Erythropoiesis-Stimulating Agents (ESAs) | European patent on stem cells may be a possibility >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | العربية | Nederlands | Finnish | Русский | Svenska | Polski

A food supplement that could prevent the development of diabetes and atherosclerosis

Published on March 11, 2007 at 3:10 PM · No Comments

The health benefits of cutting down on dietary saturated fatty acids and including higher levels of unsaturated fatty acids are well documented. Nutritional research is focusing on the effects of incorporating these healthier fatty acids, such as conjugated linoleic acid (CLA), into animal and human diets. CLA is present in dairy products and meat from ruminants and in very low amounts in our bodies.

Health benefits of conjugated linoleic acid (CLA) Dr Helen Roche, a senior lecturer in molecular nutrition in Trinity College Dublin, has been studying CLA and its biological properties for several years. "CLA seems to protect cells programmed to become diabetic against development of diabetes and it also prevents disease processes that lead to atherosclerosis, chronic inflammation and colon cancer," says Dr Roche.

Classified as a nutraceutical or nutritional supplement, CLA is thought to change the balance between fat cells and muscle cells in the body and is currently on sale in health shops as a supplement to help people improve their body tone.

"The problem is that commercially available supplements contain two forms of the compound known as isomers," explains Dr Paul Evans, a researcher with the Centre for Synthesis and Chemical Biology (CSCB). "Isomers are molecules that have the same molecular formula but the atoms are arranged differently in space. In the case of CLA one isomer known as cis-9-trans-11 CLA has beneficial effects but the other form, trans-10-cis-12 CLA, can be detrimental and could induce a diabetic state."

Discovering a selective way to synthesise the beneficial CLA isomer Dr Evans and his group while working at the School of Chemistry in Trinity College Dublin discovered a way to selectively synthesise the beneficial cis-9-trans-11 CLA in large quantities.

During the CLA project the group also found a method for making trans-vaccenic acid (TVA), the precursor to CLA. Evidence suggests that TVA is converted into CLA by an enzyme in the bovine mammary gland and muscle and by a bacterial enzyme in the human intestine.

"Now that we have a supply of the beneficial form of CLA and TVA we can carry out nutritional studies to determine whether the health effects ascribed to CLA are due to the fatty acid alone or attributable to the metabolic conversion of TVA into CLA," says Dr Roche.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading